Biofrontera
BFRI
15 hedge funds and large institutions have $1.53M invested in Biofrontera in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 2 closing their positions.
150% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 2
100% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 3
25% more funds holding
Funds holding: 12 → 15 (+3)
0.16% more ownership
Funds ownership: 0.27% → 0.42% (+0.16%)
43% less capital invested
Capital invested by funds: $2.66M → $1.53M (-$1.13M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$2.32M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$186K |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$62.9K |
| 4 |
BA
Bard Associates
Chicago,
Illinois
|
+$40.1K |
| 5 |
BlackRock
New York
|
+$31.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$168K |
| 2 |
Two Sigma Advisers
New York
|
-$60.1K |
| 3 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$48K |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$15.2K |
| 5 |
Citigroup
New York
|
-$4.55K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BA
1
Bard Associates
Chicago,
Illinois
| $482K | +$40.1K | +660 | +5% |
|
|
2
Vanguard Group
Malvern,
Pennsylvania
| $395K | +$186K | +3,072 | +41% |
|
|
3
BlackRock
New York
| $206K | +$31.1K | +513 | +10% |
|
|
SSA
4
Schonfeld Strategic Advisors
New York
| $171K | +$7.89K | +130 | +3% |
|
5
Geode Capital Management
Boston,
Massachusetts
| $137K | +$30.7K | +506 | +16% |
|
6
State Street
Boston,
Massachusetts
| $43K | +$24.9K | +410 | +56% |
|
|
7
Northern Trust
Chicago,
Illinois
| $39K | +$62.9K | +1,036 | New |
|
|
8
Two Sigma Advisers
New York
| $30K | -$60.1K | -990 | -55% |
|
9
Jane Street
New York
| $19K | +$30.9K | +510 | New |
|
10
Osaic Holdings
Scottsdale,
Arizona
| $4K | +$7.22K | +119 | New |
|
|
AC
11
Armistice Capital
New York
| $1.42K | +$2.32M | +38,182 | New |
|
|
12
Citigroup
New York
| $1K | -$4.55K | -75 | -75% |
|
|
13
Bank of Montreal
Toronto,
Ontario, Canada
| $62 | -$15.2K | -250 | -17% |
|
|
14
Citadel Advisors
Miami,
Florida
| – | -$168K | -2,525 | Closed |
|
|
XT
15
XTX Topco
George Town,
Cayman Islands
| – | -$48K | -717 | Closed |
|
16
Simplex Trading
Chicago,
Illinois
| – | +$850 | +14 | New |
|
BFRI Hedge Fund Activity: Q2 2022 in Review
15 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Biofrontera (BFRI) for Q2 2022, worth a combined $1.53M — down 43% from $2.66M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new BFRI positions and 2 closed out — a net gain of 3 holders — while 6 added to existing stakes and 3 trimmed.
The largest buyer was Armistice Capital, opening a new position worth an estimated $2.32M. The largest seller was Citadel Advisors, exiting entirely with an estimated $168K sold.
- 15 institutional investors held Biofrontera (BFRI) as of Q2 2022, up from 12 in Q1 2022.
- Funds reported $1.53M of Biofrontera stock for Q2 2022, down 43% quarter-over-quarter.
- 5 funds opened new Biofrontera positions in Q2 2022 and 2 closed out, a net change of +3 holders.
- The largest Biofrontera buyer in Q2 2022 was Armistice Capital, an estimated $2.32M added.
- The largest Biofrontera seller in Q2 2022 was Citadel Advisors, an estimated $168K sold.
Based on aggregated 13F filings for Q2 2022.